Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Celanese (CE) Equity Income (2016 - 2025)

Historic Equity Income for Celanese (CE) over the last 17 years, with Q3 2025 value amounting to $39.0 million.

  • Celanese's Equity Income fell 2352.94% to $39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.0 million, marking a year-over-year decrease of 3827.75%. This contributed to the annual value of $196.0 million for FY2024, which is 9215.69% up from last year.
  • As of Q3 2025, Celanese's Equity Income stood at $39.0 million, which was down 2352.94% from $29.0 million recorded in Q2 2025.
  • In the past 5 years, Celanese's Equity Income ranged from a high of $73.0 million in Q3 2022 and a low of $12.0 million during Q3 2023
  • Its 5-year average for Equity Income is $39.9 million, with a median of $39.0 million in 2024.
  • Its Equity Income has fluctuated over the past 5 years, first tumbled by 8356.16% in 2023, then skyrocketed by 32500.0% in 2024.
  • Over the past 5 years, Celanese's Equity Income (Quarter) stood at $44.0 million in 2021, then fell by 29.55% to $31.0 million in 2022, then skyrocketed by 67.74% to $52.0 million in 2023, then dropped by 25.0% to $39.0 million in 2024, then changed by 0.0% to $39.0 million in 2025.
  • Its Equity Income stands at $39.0 million for Q3 2025, versus $29.0 million for Q2 2025 and $22.0 million for Q1 2025.